Shri Ahimsa Naturals raises ₹12.09 Cr via allotment of 7.10 lakh shares on warrant conversion
Shri Ahimsa Naturals has approved the allotment of 7,10,400 equity shares of face value ₹10 each following the conversion of warrants issued on a preferential basis. The allotment was executed at an issue price of ₹227 per share (including a premium of ₹217) after receiving the remaining 75% consideration totaling ₹12.09 Cr from three public investors. Consequently, the company's paid-up equity share capital increases from 2,38,08,500 shares (₹23.81 Cr) to 2,45,18,900 shares (₹24.52 Cr). This follows an earlier tranche of 3,77,600 warrants converted in May 2026 out of the 13,34,400 warrants initially issued.
high confidence
What changedConversion of 7,10,400 preferential warrants into fully paid equity shares upon receipt of the final 75% tranche of ₹12.09 Cr.
Why it mattersInfuses ₹12.09 Cr of fresh equity capital to bolster cash reserves or fund expansions, resulting in an equity dilution of ~2.98% of the expanded base.
Equity shares allotted: 7,10,400Issue price per share: Rs 227Amount received (75%): Rs 12,09,45,600Paid-up capital post-allotment: Rs 24,51,89,000
📅 Short termMinor equity dilution of existing shareholders; the newly issued shares will be listed and rank pari-passu with existing equity.
📈 Long termStrengthens equity base and provides non-debt cash flow, useful for supporting the company's stated goal of scaling capacity via its SAHPL subsidiary.
⚠ Risk flags
- Equity dilution of existing shareholders (~2.98%)
👀 What to Watch
Track the deployment of the ₹12.09 Cr warrant proceeds, particularly toward the ongoing ₹35 Cr SAHPL capacity expansion project, and monitor the conversion status of the remaining warrants.
